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Abstract
The bradykinin (BK) B2 and B1 receptors (B2R, B1R) belong
to the rhodopsin-like G protein-coupled receptors (GPCRs)
and are involved in (patho)physiological processes such as
blood pressure regulation or inflammation. They mediate the
effects of the pro-inflammatory peptides bradykinin/kallidin
and desArg9-BK/desArg10-kallidin, respectively. Whereas the
B2R is constitutively expressed and gets internalized upon
activation, the B1R is especially induced by inflammatory
mediators and responds to stimulation with increased surface
receptor numbers. Stimulation of both receptors activates
phospholipase Cb (PLCb) and mitogen activated protein
kinase (MAPK) signaling. Because inflammatory processes
are characterized by heat (fever), we analyzed the effect of
increased temperature (418C vs. 378C) on B1R and B2R sig-
naling in HEK 293 and IMR 90 cells. Our results show that
signaling of both receptors is temperature-sensitive,
however to a different extent and with regard to the inves-
tigated pathways. Comparing PLCb activity and Ca2q-reg-
ulated signals, a temperature-dependent increase was only
observed for B1R but not for B2R activation, whereas MAPK
activities were doubled at 418C for both receptors. Taken
together, our findings suggest that the observed temperature
sensitivity of B1R-induced PLCb activation is B1R-specific.
In contrast, the enhanced stimulation of MAPK activity
under hyperthermic conditions appears to be a common phe-
nomenon for GPCRs.
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Introduction
The bradykinin (BK) B1 and B2 receptors (B1R and B2R)
belong to the family A (rhodopsin/b2-adrenergic like) of G
protein-coupled receptors (GPCRs) and mediate the effects
of the pro-inflammatory peptides desArg9-BK/desArg10-
kallidin (DABK/DAK) and BK/kallidin (Lys-BK), respec-
tively. The latter two are often released at sites of
inflammation from high- and low-molecular-weight kinino-
gens through the action of kallikreins (Bhoola et al., 1992;
Leeb-Lundberg et al., 2005) and can be converted into their
desArg-derivatives by carboxypeptidases. Both receptors are
involved in numerous (patho)physiological processes includ-
ing blood pressure regulation, edema formation, pain sensa-
tion, inflammation, regulation of cell growth, differentiation,
and mobility (Blaukat et al., 2000; Fredriksson et al., 2003;
Rosenbaum et al., 2009). They have been reported to play a
role in various diseases such as septic shock, atherosclerosis,
and diabetes (Leeb-Lundberg et al., 2005). Although B1R
and B2R couple to the same G proteins, Gq/11 and Gi, they
differ considerably with regard to their regulation and the
dynamics of their subcellular localization. B2R is constitu-
tively expressed in many cell types mediating the majority
of physiological kinin effects under normal conditions. It
gets rapidly internalized and desensitized after activation. In
contrast, B1R is expressed only weakly in healthy surround-
ings but is potently induced by pro-inflammatory cytokines
in pathological situations such as sepsis or minor inflam-
mation. Moreover, unlike B2R, B1R does not become desen-
sitized and responds in some cell types to activation with an
increase in surface receptor number rather than internaliza-
tion, e.g., in IMR 90 cells (Phagoo et al., 2000; Leeb-Lund-
berg et al., 2005). As both kinin receptors participate in
inflammatory processes by mediating the release of pro-
inflammatory cytokines and recruitment of immune cells
(McLean et al., 2000; Leeb-Lundberg et al., 2005; Ehrenfeld
et al., 2006), the properties of the B1R indicate sustained
signaling and thus a role in the prolonged phase of the
immune response with amplification of inflammatory pro-
cesses (Blaukat et al., 1996; Austin et al., 1997; Marceau
et al., 1998; Faussner et al., 1999; Phagoo et al., 2000; Mar-
ceau et al., 2002; Leeb-Lundberg et al., 2005). Inflammation
is characterized by five cardinal symptoms: pain, redness,
swelling, loss of function, and heat (Elliott et al., 1960).
Infection or massive inflammation are often associated with
fever and the pro-inflammatory stimuli we.g., lipopolysaccha-
ride, Interleukin-1b (IL-1b)x that promote B1R expression
are also effective inducers of the febrile response causing a
strong increase of body temperature up to 428C (Jansky et
al., 1995; Roth and De Souza, 2001). So far, however, very
little information is available on how fever affects the recep-
tors and their signaling. Consequently, in the present study
we analyzed the effect of elevated temperature (378C vs.
418C) on various signaling activities of the kinin receptors.
Our findings illustrate for the first time that both B1R and
B2R are temperature-sensitive, however to a different degree
with regard to distinct signal pathways. Specifically, B1R
downstream signal transduction is significantly enhanced
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Figure 1 B1R- and B2R-stimulated accumulation of inositol phosphates at 378C vs. 418C.
(A) HEK 293 cells, stably expressing comparable amounts of either B1R or B2R, were stimulated in the presence of 50 mM LiCl for 30 min
with 1 mM of the appropriate agonist (DAK or BK) at the indicated temperature. Thereafter, total inositol phosphate (IP) was determined
as described under ‘Materials and methods’. Each value represents the mean"SEM of four independent experiments performed in triplicate.
The results are presented as fold increase over the IP content of identically treated control cells at 48C. (B) IP accumulation in IMR 90
cells stimulated for 30 min with 1 mM DAK at either 378C or 418C. Each value represents the mean"SEM of three independent experiments
performed in triplicate. The results are presented as fold increase over the IP content of identically treated control cells at 48C. (One-way
ANOVA with Bonferroni: **p-0.01, ***p-0.001).
under hyperthermic conditions (418C), supporting the notion
that B2R activation governs the physiological kinin effects,
whereas the B1R prolongs and amplifies these effects under
pathological conditions (Dray, 1997).
Results
Heat development is one of the five cardinal signs of inflam-
mation, which often is associated with an increase in body
temperature (fever). To investigate the effects of fever on
receptor signaling, we chose the kinin receptors (B1R, B2R),
as their endogenous agonists bradykinin (BK) and desArg10-
kallidin (DAK) are pro-inflammatory peptides. In detail, we
studied the short- and long-term effects of an increase in
temperature from 378C to 418C on selected signaling path-
ways (PLCb, NFAT, MAPK, AP-1).
Increase of B1R- but not of B2R-stimulated PLCb
activity at 418C
Stimulation of B1R as well as of B2R results in activation of
phospholipase Cb (PLCb), which hydrolyses phosphatidy-
linositol 4,5-bisphosphate (PIP2) to diacylglycerol (DAG)
and inositol 1,4,5-trisphosphate (IP3), thereby activating
protein kinase C (PKC) and increasing intracellular calcium
wCa2qx concentrations. To analyze PLCb activity, total IP
accumulation was measured upon receptor activation with 1
mM of the respective agonist, in stably transfected HEK 293
cells at either 378C or 418C. Stimulation of B1R with DAK
at 378C resulted in an eight-fold increase of IP accumulation
and turned almost 14-fold when the stimulation was per-
formed at 418C (Figure 1A). In contrast, activation of B2R
with BK caused a four-fold increase over basal in PLCb
activity at 378C, which was not further elevated by raising
the temperature to 418C (Figure 1A). Basal B1R-mediated
PLCb activation displayed a non-significant tendency to be
increased by the enhanced temperature. We also determined
the EC50 values for total IP accumulation after B1R stimu-
lation at 378C and 418C, but in two experiments no differ-
ence was observed (0.8/0.9 nM at 378C vs. 0.6/1.5 nM at
418C).
Expressing the B1R under the control of the strong cyto-
megalovirus (CMV) promoter and the B2R under the control
of the weaker promoter Pmin led to comparable protein levels
of the B1R and the B2R (1200–2000 fmol/mg protein) in our
HEK 293 cells, as determined by radioligand binding assays
(Faussner et al., 2009) and therefore similar signaling activ-
ity. However, to exclude that our observations resulted solely
from this heterologous B1 and B2 receptor overexpression,
we reproduced our findings in the human embryonic lung
fibroblast cell line IMR 90, which endogenously expresses
the B2R (300–800 fmol/mg protein). To perform our exper-
iments in these primary cells, the normally low B1R levels
(20–50 fmol/mg protein) were induced (100–400 fmol/mg
protein) by pre-treatment with IL-1b (2.5 ng/ml) for 4 h,
which should reflect a physiologic situation as IL-1b is an
endogenous pyrogen involved in the febrile response (Jansky
et al., 1995; Roth and De Souza, 2001). PLCb activation via
the B1R was significantly increased in DAK-stimulated IMR
90 cells at 418C as compared to the level at 378C (Figure
1B), whereas B2R-mediated PLCb activity remained at the
same level as at 378C (data not shown). Thus, the response
of both receptors in the IMR 90 cells reflects their temper-
ature dependency found in the HEK 293 cells, demonstrating
that it is not artifact caused by heterologous receptor
overexpression.
We further established that high temperature treatment has
no significant influence on cell surface receptor density by
radioligand binding assays following incubation at 378C and
418C in both cell lines (data not shown).
Next we investigated whether the stronger signaling at
418C vs. 378C could also be observed further downstream in
the IP signaling cascade.
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Figure 2 B1R- and B2R-mediated induction of NFAT-regulated
Gaussia luciferase activity.
NFAT reporter gene host cells on 24-wells transiently expressing
B1R or B2R were stimulated in DMEM containing 0.5% FCS with
1 mM of the appropriate agonist (DAK or BK) for 10 min at 378C
or 418C. After further incubation in DMEM with 0.5% FCS for
24 h at 378C or 418C, respectively, luciferase activity was measured
as described under ‘material and methods’ and normalized to stim-
ulated luciferase activity at 378C, which was 4"0.8-fold over basal
activity following B1R stimulation and 5"0.7-fold after B2R acti-
vation. Values represent means"SEM of seven independent exper-
iments performed in triplicate. (One-way ANOVA with
Dunnett: **p-0.01.)
Elevation of B1R- but not of B2R-activated
Ca2H-dependent signaling at 418C
When intracellular Ca2q concentrations are increased, Ca2q
binds to calmodulin, which consequently activates the phos-
phatase calcineurin. Calcineurin in turn dephosphorylates the
nuclear factor of activated T-cells (NFAT) transcription fac-
tor, allowing it to translocate into the nucleus and regulate
gene expression by binding to its responsive elements
(Muller and Rao, 2010). In our specific HEK 293 reporter
cell line, the nuclear NFAT transcription factor promotes the
expression of the reporter gene Gaussia luciferase. The
NFAT reporter host cell line transiently expressing B1R or
B2R was stimulated with DAK or BK (1 mM each), respec-
tively, and Gaussia luciferase activity was determined 24 h
later. NFAT-mediated luciferase action following B1R stim-
ulation with DAK at 418C was increased two-fold as com-
pared to the effects of a stimulation performed at 378C. In
contrast, NFAT-mediated Gaussia luciferase activity induced
by B2R stimulation with BK remained the same at 418C as
at 378C (Figure 2). These findings are consistent with the
already described observations concerning the short-term
stimulation of PLCb activity (Figure 1) and confirm that the
higher temperature (418C) increases only B1R- but not B2R-
activated Ca2q-dependent signals.
Requirement of Gq/11 and Gi for ERK1/2 activation
via B1R and B2R
Both kinin receptors activate the MAPK signaling cascade,
which is involved in major cellular processes such as cell
growth, development, differentiation, and proliferation
(Dhanasekaran et al., 1998; Dhillon et al., 2007; Zhang and
Dong, 2007). Consequently, we analyzed the influence of
increased temperature on the PKC-mediated extracellular
signal-regulated kinase 1/2 (ERK1/2) pathway of the MAPK
signaling cascades. It has been reported that efficient B2R-
mediated MAPK activation requires coupling to both Gq/11
and Gi (Blaukat et al., 2000). As little was known, however,
about the requirements of B1R-mediated MAPK stimulation,
we first addressed the question of whether the B1R also
belongs to the group of dually coupled receptors (to Gq/11
and Gi protein subtypes) with regard to MAPK signal trans-
mission, before analyzing the existence of a temperature
dependence of B1R- and B2R-mediated signaling. In order to
determine the contribution of Gq/11, HEK 293 cells stably
expressing the B1R or the B2R were treated for 30 min with
5 mM BIM (bisindolylmaleimide), a potent PKC inhibitor, or
for 16 h with 75 ng/ml Ptx (pertussis toxin) to inactivate Gi.
Thereafter, ERK1/2 phosphorylation was determined upon
stimulation of B1R and B2R with 1 mM of the respective
receptor ligand for 5 min. Treatment with 1 mM PMA (phor-
bol-12-myristate-13-acetate), a strong PKC activator, for
10 min served as positive control and reference for maximal
response. The DAK- and BK-induced increases in ERK1/2
phosphorylation were cut by approximately half upon pre-
treatment with BIM or Ptx, revealing a contribution of Gq/11
for efficient signal transduction, as well as the necessity of
Gi-coupling (Figure 3A, B). The combined treatment with
the PKC- and Gi-inhibiting agents had an additive effect on
ERK1/2 phosphorylation for both kinin receptors, leading to
an almost complete inhibition of ERK1/2 activation (Figure
3A, B). These results demonstrate that the B1R also belongs
to the group of receptors that are dually coupled to efficiently
activate MAPK signaling.
Increase of B1R- and B2R-mediated ERK1/2
phosphorylation at 418C
To determine the ERK1/2 activation potential in an inflam-
matory environment with increased temperatures, we firstly
stimulated B1R- or B2R-expressing HEK 293 cells with
100 nM of the appropriate receptor agonist at 378C and at
418C for different time periods. Again, stimulation with
PMA (1 mM) served as positive control and reference of
maximal response. ERK1/2 phosphorylation was increased
at 418C as compared to the activity level at 378C following
stimulation of B1R as well as of B2R (Figure 4A, B). The
differences in ERK1/2 activation between 378C and 418C
were most prominent after 5 and 10 min of stimulation of
both receptors. Stimulation of B1R with DAK for 5 and
10 min resulted in a 26–31% increase of ERK1/2 phospho-
rylation at 418C compared to 378C. Triggering the B2R also
led to a significant signal elevation (18–21%) at 418C as
compared to 378C after 5 and 10 min. A clear increase of
ERK1/2 activation after stimulation of B1R or B2R was also
found in IMR 90 cells at 418C as compared to 378C (Figure
4C), proving the potential physiological relevance of aug-
mented receptor-mediated MAPK signaling activity at higher
temperatures that occur during fever in inflammatory proc-
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Figure 3 B1R- and B2R-stimulated activation of ERK1/2 involving G proteins Gq/11 and Gi.
(A) Western blot of phospho- and total-ERK1/2. HEK 293 cells stably expressing B1R and B2R were serum-starved overnight, pre-treated
for 30 min with 5 mM BIM or for 16 h with 75 ng/ml Ptx and stimulated for 5 min with 1 mM DAK or BK as indicated. (B) Levels of
phosphorylated ERK1/2 were quantified with ImageJ as described under ‘Materials and methods’, corrected for quantified total-ERK1/2
levels and normalized to the results obtained with 1 mM PMA (5 min) that served as reference for maximal response (s100%). Values
represent means"SEM of four independent experiments. (One-way ANOVA with Bonferroni: *p-0.05, **p-0.01, ***p-0.001,  not
significant compared to unstimulated.)
esses. Pre-incubation with 1 mM of Lys-des-Arg9-wLeu8x-BK
(B1R antagonist) or with 1 mM of Icatibant (B2R antagonist)
completely inhibited ERK1/2 phosphorylation, verifying sig-
nal transmission via the above-mentioned receptors (Figure
4A). Unlike the results observed for PLCb-mediated and
Ca2q-regulated signal transduction, these findings show that
with regard to ERK1/2 pathway activation, signaling activity
of both kinin receptors increases with the temperature rise.
This temperature sensitivity, however, is apparently a prop-
erty of the ERK1/2 pathway itself, as it was basically also
observed with the direct stimulation using PMA, however
not reaching statistical significance (increases of 25"12%
and 21"16% (ns4) of phospho-ERK1/2 levels at 418C as
compared to 378C following PMA treatment of B1R or B2R-
expressing cells, respectively; Figure 4A).
Elevation of AP-1-mediated reporter activity
via B1R and B2R at 418C
The ERK1/2/MAPK pathway was reported to possibly par-
ticipate in the regulation of activator protein 1 (AP-1), a tran-
scription factor comprised of JUN homo- or FOS-JUN
heterodimers (Yordy and Muise-Helmericks, 2000; Pruitt and
Der, 2001). AP-1 expression results in the regulation of key
cell cycle regulators such as D-type cyclins, enabling the cell
to progress through the G1 phase of the cell cycle (Yordy
and Muise-Helmericks, 2000; Pruitt and Der, 2001). In order
to detect temperature-sensitive long-term effects of B1R and
B2R signaling in the context of ERK1/2 signal transduction,
we investigated the temperature dependence of B1R and B2R
concerning their ability to activate AP-1-promoted Gaussia
luciferase gene expression.
An AP-1 reporter cell line transiently expressing the B1R
or B2R was stimulated for 10 min at 378C or 418C with 1 mM
of DAK or BK, respectively. After 24 h of further incubation
at the same temperature, Gaussia luciferase activity was
monitored. A four- to five-fold increase in enzyme activity
was observed at 418C as compared to 378C following stim-
ulation of both receptors (Figure 5). These findings are in
agreement with our observations regarding B1R- or B2R-
dependent ERK1/2 phosphorylation (Figure 4), rendering a
participation of the ERK1/2 pathway in AP-1 transcription
factor regulation feasible.
Discussion
Although pathological situations such as severe inflammation
are often associated with fever, little is known on how a
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Figure 4 B1R- and B2R-induced ERK1/2 activation.
(A) Western blot of phospho- and total-ERK1/2. HEK 293 cells stably expressing B1R or B2R were serum-starved overnight, stimulated
with 100 nM DAK/BK with or without pre-incubation with the appropriate antagonist (Ant) at 378C and 418C for the indicated times. (B)
Phospho- and total-ERK1/2 protein levels were quantified and normalized as described under ‘Material and methods’. Results of PMA
treatment (1 mM, 5 min) served as positive control and reference for maximal response (s100%). Values represent means"SEM of four
independent experiments (paired Student t-test: **p-0.01, *p-0.05). (C) ERK1/2 phosphorylation in IMR 90 cells. The experiment was
performed as described for HEK 293 cells. The data of the quantification of one Western blot are shown. A second blot gave identical
results.
temperature increase modifies stimulation and the following
signaling of cellular membrane receptors. Such information
could help to decide whether to fight against fever or to
accept the temperature rise as therapeutically useful. As kinin
receptors are the mediators of the effects of the pro-
inflammatory kinin peptide hormones under inflammatory
pathological conditions (e.g., sepsis) (Marceau et al., 2002;
Leeb-Lundberg et al., 2005), these receptors appeared to be
ideal to perform investigations on the temperature sensitivity
of membrane receptors.
In our study, we looked at four different signaling path-
ways (depicted in Figure 6), comprising short-term effects
of receptor activation (PI hydrolysis and ERK1/2 activation)
as well as long-term effects (NFAT- and AP-1-reporter activ-
ity). Our results show that one has to differentiate between
the influences of an increase in temperature on the signaling
pathways themselves and effects that are specific for a recep-
tor activating these pathways.
ERK1/2 phosphorylation and AP-1-regulated reporter
gene activation were significantly enhanced at 418C as com-
pared to 378C upon stimulation of both kinin receptors. This
temperature dependency was basically also observed when
the ERK1/2 pathway was stimulated with the phorbolester
PMA, however not reaching statistical significance wwith
increases of 21–24% in ERK1/2 phosphorylation at 418C as
compared to 378C (see Figure 4) and 1.7"0.3-fold enhanced
AP-1 reporter activity at 418C over 378C (see Figure 5)x, i.e.,
without the initial receptor and G protein activation step. The
augmented ERK1/2 activation at 418C may, therefore, not be
specific for the kinin receptors, but can also most likely be
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Figure 5 B1R- and B2R-mediated induction of AP-1-regulated
Gaussia luciferase activity.
AP-1 reporter gene host cells on 24-wells transiently expressing B1R
or B2R were stimulated in DMEM containing 0.5% FCS with 1 mM
of the appropriate agonist (DAK or BK) for 10 min at 378C or 418C.
After further incubation in DMEM with 0.5% FCS for 24 h at 378C
or 418C, respectively, luciferase activity was measured as described
under ‘Material and methods’ and normalized to stimulated lucif-
erase activity at 378C, which was 6"2-fold over basal activity fol-
lowing B1R stimulation and 3"1-fold after B2R activation. Values
represent means"SEM of five independent experiments performed
in triplicate. (One-way ANOVA with Dunnett: *p-0.05.)
Figure 6 Overview of B1R- and B2R-mediated pathways at 378C
vs. 418C.
Bold arrows indicate increased signal activity at 418C as compared
to 378C. Light gray arrows show B1R-specific temperature depend-
ence, while black arrows show pathway-specific temperature
dependency. Both kinin receptors are temperature-sensitive. How-
ever, mainly B1R signaling activity is strongly enhanced at elevated
temperatures.detected for other GPCRs activating this pathway. The effect
of a temperature rise on ERK1/2 activation was also appar-
ently not dependent on the cell type as it was assessed for
the kinin receptors heterologously expressed in HEK 293
cells and for those expressed endogenously in IMR 90 fibro-
blasts as well (see Figure 4C).
In contrast, a temperature sensitivity of PI hydrolysis or
the NFAT-regulated reporter activity was found only after
stimulation of the B1R, but not of the B2R (see Figure 1 and
Figure 2). This indicates that the responses of these two path-
ways are not generally enhanced with temperature, but solely
when activated via specific receptors such as the B1R. As
shown in different cell types (HEK 293, IMR 90 fibroblasts),
the temperature sensitivity is not a common property of the
pathway, but rather an intrinsic quality of the respective
receptor, in our case of the B1R.
Although both kinin receptors apparently couple to the
same signaling pathways, thereby activating identical
second messengers and kinase cascades, they otherwise
exhibit quite contrasting regulatory patterns. The B2R gets
rapidly phosphorylated, desensitized, and internalized upon
stimulation with an agonist. In contrast, the B1R does not
become phosphorylated and does not undergo agonist-
induced desensitization (Leeb-Lundberg et al., 2005). Con-
sequently, while the B2R induces a transient increase in PI
hydrolysis and is only weakly dependent on extracellular
Ca2q, the B1R promotes sustained signaling and is signifi-
cantly dependent on extracellular Ca2q (Tropea et al., 1993;
Leeb-Lundberg et al., 2005). Moreover, in contrast to the
B2R, which is constitutively expressed in many cells, the B1R
is induced preferentially under pathological conditions by
inflammatory cytokines (Leeb-Lundberg et al., 2005).
All these differences led to the assumption that the B2R
acts during the acute phase of an inflammation or other path-
ological situations, whereas the B1R takes over as
(patho)physiologically dominating kinin receptor in the
chronic phase after being expressed in sufficient amounts
(Enquist et al., 2007). The observed different temperature
sensitivity of both receptors in our experiments further
strengthens this notion of a switch from B2R to enhanced
B1R signal transduction in an inflammatory situation with
elevated temperatures. Future studies will have to determine
how the specifically increased B1R signaling is achieved,
whether through enhanced efficacy as a guanine-nucleotide
exchange factor for G proteins or via other temperature-
sensitive factors (e.g., Ca2q channels translocated to the plas-
ma membrane), which may exert their augmenting effect
sufficiently only with receptors that do not become imme-
diately desensitized, such as the B1R.
Furthermore, several studies have demonstrated that kinin
receptors are involved in leukocyte migration, and are up-
regulated on neutrophils in a variety of inflammatory disor-
ders, e.g., asthma and rheumatoid arthritis (Bertram et al.,
2007). The temperature sensitivity of the kinin receptors, as
observed by us, is therefore most likely of therapeutic rele-
vance. In this context, it is of interest that Gouveia et al.
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recently reported that the application of the drug lovastatin
to rats with pilocarpine-induced status epilepticus resulted in
a reduction of body temperature, in decreased IL-1b and IL-
6 levels, and importantly in a decline of B1R expression. The
authors concluded that normalization of body temperature
could be an approach of neuroprotection in generalized con-
vulsive forms of status epilepticus (Gouveia et al., 2011).
Assuming that B1R signaling is increased during status epi-
lepticus due to higher temperatures, neuroprotection might
occur partly because of a diminution of B1R activity at nor-
mal physiological temperatures.
Interestingly, it is worth mentioning that GPCRs cannot
only be affected in their signaling properties by the surround-
ing temperature as shown herein, but may even act as a tem-
perature sensor as has recently been reported for the GPCR
rhodopsin in Drosophila larvae (Shen et al., 2011).
Taken together, our findings illustrate, to the best of our
knowledge for the first time, that some GPCR signaling path-
ways (e.g., ERK1/2, AP-1) are significantly affected by the
(patho)physiologically relevant temperature increase from
378C to 418C and thus most likely will respond to all acti-
vating GPCRs with a stronger signal at the higher tempera-
ture. In contrast, other pathways (e.g., PI hydrolysis, NFAT)
are basically insensitive to (patho)physiological temperature
alterations. An observed effect of temperature on a response
in these cases is therefore specific for the activating receptor,
as demonstrated for the B1R in our experiments. Since the
signaling activity of the B1R is specifically increased in
hyperthermic surroundings in addition to its upregulation
under fever-associated inflammatory conditions, targeting
this GPCR might be of special therapeutic relevance for the
decision of whether or not to counteract fever.
Materials and methods
Materials
Flp-In TREx-293 (HEK 293) cells were bought from Invitrogen
(Karlsruhe, Germany) and IMR 90 cells from ATCC (Manassas,
USA). w2,3-prolyl-3,4-3Hxbradykinin (80 Ci/mmol) and myo-w2-
3Hxinositol (22 Ci/mmol) were purchased from Perkin Elmer Life
Sciences (Boston, USA), Kallidinwdes-Arg10x,w3,4-Prolyl-3,4-3Hx
(70 Ci/mmol) from Hartmann Analytic (Braunschweig, Germany).
Bradykinin and desArg10-Kallidin were synthesized by Bachem
(Heidelberg, Germany). Fugene was from Roche (Mannheim,
Germany), EcoTransfect from Oz Biosciences (Marseille, France).
Poly-D-Lysine, captopril, 1.10-phenanthroline, bacitracin and
pertussis toxin were obtained from Sigma-Aldrich (Taufkirchen,
Germany). Cell culture media and additions were from PAA Labo-
ratories (Coelbe, Germany), Opti-MEM I from Gibco (Darmstadt,
Germany). Bisindolylmaleimide I, phorbol-12-myristate-13-acetate
and ionomycin were purchased from Calbiochem (Darmstadt,
Germany). Monoclonal phospho-ERK1/2- and ERK1/2-antibodies,
as well as the peroxidase-labeled horse anti-mouse IgG-antibody
were supplied by Cell Signaling Technology (Massachusetts, USA).
Gene expression and cell culture
The sequence of the B1R, codon-optimized for expression in human
cells and synthesized by GeneArt (Regensburg, Germany) and the
sequence of the B2R starting with the third encoded Met (Hess
et al., 1992), were cloned into the HindIII and XhoI sites of the
pcDNA5/FRT/TO vector (Invitrogen). A hemagglutinin-tag (MGY-
PYDVPDYAGS) preceded the receptor sequences. For stable
expression, the Flp-In system with the host cell line Flp-In TREx-
293 (HEK 293) and recombinase-directed insertion of the plasmid
harboring the gene of interest was applied. The HEK 293 cells cul-
tivated in Dulbecco’s modified Eagle’s Medium (DMEM) with 10%
FCS and penicillin (100 U/ml)/streptomycin (100 mg/ml) were
transfected using the transfection reagent Fugene according to the
manufacturer’s instructions. Selection of stable clones was achieved
using hygromycin B (250 mg/ml). IMR 90 cells were cultured in
minimum essential medium Eagle (MEM) with Earle’s Salts (10%
FCS, 1% glutamine). To generate reporter gene host cell lines, HEK
293 cells were stably transfected with a pcDNA3.1/G418 vector
(Invitrogen), which had the CMV promoter replaced by the respec-
tive transcriptional response elements inserted in multiple copies
(4=GGAGGAAAAACTGTTTCATACAGAAAGGCGT for NFAT,
6=AGCCTGACGTCAGAG for AP-1) followed by the Gaussia
luciferase gene cloned into the EcoRI and XhoI sites of the vector
(Larissa Ring et al., unpublished results). Cells were selected in the
presence of G418 (1 mg/ml).
Radioligand binding assays
Monolayers of IMR 90 cells or stably transfected HEK 293 cells in
24-wells were rinsed twice with ice-cold PBS and incubated on ice
with the respective radiolabeled agonist in incubation buffer (40 mM
PIPES, 109 mM NaCl, 5 mM KCl, 0.1% glucose, 0.05% BSA, 2 mM
CaCl2, 1 mM MgCl2, pH 7.4, degradation inhibitors for B1R: 0.5 mM
bacitracin, 0.02 mM 1.10-phenanthroline, 100 mM captopril; deg-
radation inhibitors for B2R: 2 mM bacitracin, 0.8 mM 1.10-phenan-
throline, 100 mM captopril) for 90 min. After washing with ice-cold
PBS, surface-bound w3Hx-labeled ligand was dissociated by incu-
bation (10 min, 48C) with 200 ml of ice-cold 0.5 M NaCl/0.2 M
acetic acid solution, pH 2.7, and counted in a b-counter after trans-
fer to a scintillation vial and addition of scintillation liquid. Non-
specific binding was determined in the presence of a 1000-fold
excess of non-radiolabeled ligand.
Determination of total inositol phosphate (IP) release
IMR 90 cells or stably transfected HEK 293 cells, plated on 12- or
24-wells, respectively, were labeled overnight with 1 mCi
w3Hxinositol/ml in 500/250 ml of Opti-MEM I. Cells were rinsed
twice with ice-cold PBS and pre-incubated for 90 min on ice in
incubation buffer supplemented with 50 mM LiCl with or without
1 mM of the indicated ligand. To determine EC50 values, cells were
pre-incubated with increasing concentrations (10-12–10-6 M) of
ligand solution at 48C. Cells were then stimulated for 30 min at
either 378C or 418C. Stimulation was terminated by exchange of
ligand solution for 1.5/0.75 ml of ice-cold 20 mM formic acid solu-
tion. After 60 min, the amount of total IP in the formic acid extract
was determined by column chromatography using AG 1-X8 col-
umns (Bio-Rad, Munich, Germany) as described earlier (Faussner
et al., 2009).
Determination of ERK1/2 phosphorylation
Confluent IMR 90 cells or HEK 293 cells on 6-well plates express-
ing the respective kinin receptor were serum-starved by incubation
in Opti-MEM I. After 24 h they were stimulated with 1 mM of
PMA, the given concentrations of DAK or BK for the indicated
times at the indicated temperature with or without pre-incubation
with 1 mM Lys-des-Arg9-wLeu8x-BK, 1 mM Icatibant, 5 mM BIM
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for 30 min, or pertussis toxin (75 ng/ml) for 16 h. Subsequently,
the monolayers were washed with ice-cold PBS, scraped in lysis
buffer (10 mM Tris-HCl, pH 7,4, 150 mM NaCl, 25 mM KCl, 0.1%
Triton X-100) supplemented with a protease inhibitor cocktail (com-
plete Mini, EDTA-free; Roche, Mannheim, Germany) and centri-
fuged at 14 000 rpm for 15 min at 48C. Cell lysates were mixed
with NuPAGE LDS Sample Buffer (Invitrogen) supplemented with
DTT (0.1 M) and heated at 998C for 10 min. Equal amounts of
protein were separated by 4–12% SDS-PAGE and transferred to a
0.45-mm nitrocellulose membrane (Bio-Rad). After 60 min in
blocking buffer w5% milk powder in Tris-buffered saline with 0.1%
Tween 20 (TBST)x the primary antibodies (phospho-ERK1/2,
ERK1/2, monoclonal, Cell Signaling) were added for 60 min in
blocking buffer. After washing with TBST the secondary peroxi-
dase-labeled horse anti-mouse IgG (Cell Signaling) was added for
60 min in blocking buffer, followed by thorough washing and visu-
alization of the immuno-labeled proteins using Western blot Chem-
iluminescence Reagent Plus (Roche) on X-ray hyperchemilumin-
escence films (Hyperfilm ECL, GE Healthcare). Band densities
were quantified using the according software, ImageJ (Abramoff et
al., 2004; Rasband, 1997–2011). Protein levels were normalized to
the corresponding PMA-stimulated phospho-ERK1/2 levels at 378C
as maximum responses.
Reporter gene assays
Reporter host cell lines on 24-wells were transiently transfected with
B1R or B2R using the transfection reagent EcoTransfect (0.2 mg
DNA/0.6 ml EcoTransfect per well) and incubated overnight in
complete cell culture medium. The next day, cells were induced with
tetracyclin (0.5 mg/ml) in medium with reduced FCS (0.5%). 24 h
later, cells were stimulated for 10 min at 378C or 418C with 1 mM
of the respective ligand (DAK/BK) and further incubated at 378C
or 418C overnight. 1 mM PMA"1 mM ionomycin served as positive
controls as indicated. 24 h post stimulation, 75 ml of the cell culture
supernatant, containing secreted Gaussia luciferase, was transferred
to a 96-well plate. Upon addition of 25 ml of Gaussia luciferase
substrate (5.72 mM Coelenterazin, 2.2 mM Na2EDTA, 0.22 M
KxPO4, pH 5.1; 0.44 mg/ml BSA, 1.1 M NaCl, 1.3 mM NaN2, pH
5.0), its activity was monitored within 1 min in a Transluminator
DarkReader (Tecan safire2, Clare Chemical Research, Dolores,
USA), followed by quantification using XFluor4 Safire2 according
software (Tecan, Crailsheim, Germany).
Protein quantification
Total protein quantification was performed using the Micro BCA
Protein assay reagent kit from Pierce (Rockford, IL, USA) with BSA
as standard.
Data analysis
All data analysis was performed with GraphPad Prism for Macin-
tosh, Version 4.0c (GraphPad Software, Inc., San Diego, CA, USA).
Data were assessed by appropriate analysis of variance (ANOVA or
Student’s t-test), with post hoc analysis as indicated (Bonferroni or
Dunnett).
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